5-n-Nonadecylresorcinol (C19:0)

ID146
Name5-n-Nonadecylresorcinol (C19:0)
Synonyms
StructureThumb
Description
GroupPolyphenols
Sub-groupAlkylresorcinols
Exposure sourceDiet
Use
CAS number35176-46-6
PubChem ID161858
ChEBI ID
FooDB IDFDB002935
HMDB IDHMDB30956

Biomarker measurements

Biomarker concentration values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
104310471AllAdults from the university campus area in UppsalaSwedenSEbaselinePlasma, fastingGC-MS5-n-Nonadecylresorcinol (C19:0)5120.016.025.0nmol/L20.0 nmol/LCrudeAndersson 2011
105010541AllAdults from the university campus area in UppsalaSwedenSE3 monthsPlasma, fastingGC-MS5-n-Nonadecylresorcinol (C19:0)5122.017.027.0nmol/L22.0 nmol/LCrudeAndersson 2011
345034551All [by diet]Postmenopausal and premenopausal women living in the Helsinki areaFinlandFIPlasma, fastingGC-MS5-n-Nonadecylresorcinol (C19:0)5619.312.2nmol/L19.3 nmol/LCrudeAubertin-Leheudre 2008
346434691VegetariansPostmenopausal and premenopausal women living in the Helsinki areaFinlandFIPlasma, fastingGC-MS5-n-Nonadecylresorcinol (C19:0)2017.68.8nmol/L17.6 nmol/LCrudeAubertin-Leheudre 2008
347834831OmnivoresPostmenopausal and premenopausal women living in the Helsinki areaFinlandFIPlasma, fastingGC-MS5-n-Nonadecylresorcinol (C19:0)3620.113.4nmol/L20.1 nmol/LCrudeAubertin-Leheudre 2008
18550185541AllParticipants without a history of heart diseaseGermanyDEEPIC-Potsdam (European Prospective Investigation into Cancer and Nutrition)baselinePlasma, fastingGC-MS5-n-Nonadecylresorcinol (C19:0)10014.212.116.6nmol/L14.2 nmol/LCrudeMontonen 2010
18556185601AllParticipants without a history of heart diseaseGermanyDEEPIC-Potsdam (European Prospective Investigation into Cancer and Nutrition)4 monthsPlasma, fastingGC-MS5-n-Nonadecylresorcinol (C19:0)10014.111.916.6nmol/L14.1 nmol/LCrudeMontonen 2010
19074190781AllResidents of the Vasterbotten regionSwedenSEVIP cohort (Vasterbotten Intervention Project)baselinePlasma, fastingGC-MS5-n-Nonadecylresorcinol (C19:0)7312.310.314.6nmol/L12.3 nmol/LCrudeLandberg 2013

Intake values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionIntake toolIntake food coverageIntake time coverageIntake assessmentCompoundCompound detailSupplement intakes included?Measurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
101810221AllAdults from the university campus area in UppsalaSwedenSEbaselineSwedish National Food AdministrationWeighed Dietary record (3-day)5-n-Nonadecylresorcinol (C19:0)7212.010.0mg/day12.0 mg/dayCrudeAndersson 2011
103610401AllAdults from the university campus area in UppsalaSwedenSE3 monthsSwedish National Food AdministrationWeighed Dietary record (3-day)5-n-Nonadecylresorcinol (C19:0)7210.09.0mg/day10.0 mg/dayCrudeAndersson 2011

Correlation values

Reproducibility values

IDMst. IDSubject groupPopulationCountryCountry codeCohortTime definitionBiological specimenExperimental methodBiomarkerBiomarker detailArithmetic meanGeometric meanMedianUnitAdjusted onReproducibility sizeICCICC 95% CI lowerICC 95% CI upperCV% WSCV% BSVAR WSVAR BSPublication
51068AllAdults from the university campus area in UppsalaSwedenSEbaseline; 3 monthsPlasma, fastingGC-MS5-n-Nonadecylresorcinol (C19:0)nmol/L510.520.330.71Andersson 2011
24218544AllParticipants without a history of heart diseaseGermanyDEEPIC-Potsdam (European Prospective Investigation into Cancer and Nutrition)baseline; 4 monthsPlasma, fastingGC-MS5-n-Nonadecylresorcinol (C19:0)nmol/L1000.460.290.6Montonen 2010
60219066AllResidents of the Vasterbotten regionSwedenSEVIP cohort (Vasterbotten Intervention Project)baseline; 2 yearsPlasma, fastingGC-MS5-n-Nonadecylresorcinol (C19:0)nmol/L730.620.470.75Landberg 2013